COMPASS PATHWAYS PLC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
COMPASS PATHWAYS PLC (CMPS) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.06% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-03-24
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-03-31 was 3.92%, a 12.97% increase year-over-year.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-09-30 was 4.34%, a 60.74% increase year-over-year.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-06-30 was 4.16%, a 24.18% increase year-over-year.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-03-31 was 3.47%, a 110.30% increase year-over-year.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 4.06%, a 1.46% decline from fiscal 2024.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.12%, a 13.50% increase from fiscal 2023.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 3.63%, a 60.62% increase from fiscal 2022.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 2.26%, a 137.89% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2025-12-31 | 4.06% 10-K · filed 2026-03-24 | |||
| 2024-12-31 | 4.12% 10-K · filed 2026-03-24 | |||
| 2024-03-31 | 3.92% 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | 3.63% 10-K · filed 2025-02-27 | |||
| 2023-09-30 | 4.34% 10-Q · filed 2023-11-02 | 3.59% 10-Q · filed 2023-11-02 | ||
| 2023-06-30 | 4.16% 10-Q · filed 2023-08-03 | 3.55% 10-Q · filed 2023-08-03 | ||
| 2023-03-31 | 3.47% 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | 2.26% 10-K · filed 2024-02-29 | |||
| 2022-09-30 | 2.70% 10-Q · filed 2023-11-02 | 2.15% 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | 3.35% 10-Q · filed 2023-08-03 | 1.80% 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | 1.65% 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | 0.95% 10-K · filed 2024-02-29 | |||
| 2021-09-30 | 0.96% 10-Q · filed 2022-11-03 | 0.91% 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | 1.08% 10-Q · filed 2022-08-04 | 0.83% 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | 0.72% 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | 0.43% 10-K · filed 2023-02-28 | |||
| 2020-09-30 | 0.39% 6-K · filed 2021-11-09 | 0.43% 6-K · filed 2021-11-09 | ||
| 2020-06-30 | 0.42% 6-K · filed 2021-08-11 | 0.44% 6-K · filed 2021-08-11 | ||
| 2019-12-31 | 1.88% 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |